“Targeting the SARS-CoV-2 Frameshift Site Pseudoknot,” Kathryn Mouzakis (Co-PI, team lead), Amanda Hargrove (Co-PI), Research Corporation for Science Advancement (RCSA) COVID Initiative Award, 06/15/2020 – 06/14/2023, $55,000.
“Measuring HTLV-1 programmed ribosomal frameshifting in vivo,” Kathryn Mouzakis (Co-PI), Jeffrey Kieft (Co-PI), Cottrell Scholars Collaborative Catalyzing Joint Research Award, 05/05/2019 – 05/04/2022, $3,000.
“Seeding inclusive local networks for domain-specific research and teaching,” Kathryn Mouzakis (Co-PI), Mary Beth Anzovino (Co-PI), Aaron Romanowsky (Co-PI), Cottrell Scholars Collaborative MSI/PWI Partnerships Award, 08/24/2018 – 08/23/2021, $6,000.
“Structural Basis of -1 Programmed Ribosomal Frameshifting by the Human T-cell Lymphotropic Virus Type I RNA,” Kathryn Mouzakis (PI), RCSA Cottrell Scholar Award, 07/01/2017 – 12/31/2022, $100,000.
“Structural Basis of -1 Programmed Ribosomal Frameshifting by the Human T-cell Lymphotropic Virus Type I RNA,” Kathryn Mouzakis (PI), NIH Support of Competitive Research (SCORE) Pilot Project Award (SC2), 02/01/2017 – 08/15/2018, $300,000.
